biOasis Technologies Inc (BIOAF)

0.210
+0.003(+1.40%)
  • Volume:
    500
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.210 - 0.210

BIOAF Overview

Prev. Close
0.207
Day's Range
0.21-0.21
Revenue
-
Open
0.21
52 wk Range
0.178-0.451
EPS
-
Volume
500
Market Cap
14.97M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
29,241
P/E Ratio
13.13
Beta
-
1-Year Change
-44.95%
Shares Outstanding
72,144,015
Next Earnings Date
Jul. 04, 2022
What is your sentiment on biOasis Technologies Inc?
or
Market is currently closed. Voting is open during market hours.

biOasis Technologies Inc Company Profile

Employees
0
Market
Canada

Bioasis Technologies Inc. is a Canada-based development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The Company is engaged in the development of the xB3 platform, a technology for the delivery of therapeutics across the blood brain barrier (BBB) and the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. xB3 is based on a human transport protein found circulating at low levels in the blood. The xB3 platform has an efficacy in its ability to shuttle molecules across the blood-brain barrier and reach its targets within the brain through a process called receptor-mediated transcytosis. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryNeutralNeutralNeutralStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.